Business news – Page 44
-
OpinionShould individual companies be blamed for climate change?
Argument ignores consumers’ responsibility driven by our energy demands
-
-
BusinessBASF to buy Solvay’s polyamide business
€1.6bn deal covers 2400 employees at sites in Europe, Asia and the Americas
-
FeaturePhotoredox: charge of the LED brigade
Forget fluorescent light bulbs, photochemistry has become a lot more sophisticated
-
BusinessTeva to sell off women’s health businesses for $1.4bn
Deals continue Teva’s bid to get rid of non-core businesses and raise cash to service its debts
-
BusinessIndustry intervenes in chemical regulation lawsuits
Trade groups back up US EPA against environmental campaigners’ complaints of relaxation in new rules
-
BusinessAllergan sidesteps patent review with tribal deal
Native Americans agree to use sovereign immunity to protect intellectual property from double challenge
-
BusinessAlexion axes 20% of its global workforce
600 jobs lost amid restructure as firm moves to Boston life sciences hub
-
BusinessAkzoNobel paint plant is ‘world’s most sustainable’
Biomass and solar-powered UK factory will recycle water and solvents, and is more flexible to reduce waste
-
OpinionSafety lessons from Hurricane Harvey
The chemical fires triggered by extreme flooding in Houston demonstrate the need to improve risk management
-
BusinessChemours reaches truce in pollution investigation
Company will provide authorities with data on perfluorinated compound emissions into drinking water
-
OpinionAn opportunity ignored
Dismissing ideas that were ‘not invented here’ is like walking past a $100 bill
-
BusinessHurricanes’ chemical consequences
Gulf coast petrochemical plants move to restart operations, while concerns persist about the fallout from hurricane Irma
-
BusinessTeva sells off contraceptive device in $1.1bn deal
CooperSurgical to acquire Paragard as Teva seeks to offload assets
-
BusinessHB Fuller targets growth with trio of deals
Adhesives manufacturer will buy one Brazilian and two US glue companies
-
BusinessTakeda tightens focus on core areas with multiple deals
Japanese firm is remodelling its R&D efforts through collaboration and licensing deals, and selling off non-core businesses
-
BusinessFDA warns Pfizer subsidiary over Epipen malfunctions
Manufacturer did not fully investigate reports of patients dying after auto-injector failures
-
BusinessEli Lilly to cut 3500 jobs
Company will close sites in US and China, and provide incentives for early retirement
-
ArticlePharma supply chains pick up pace
Contract suppliers are increasingly important in reducing time to market
-
BusinessAsia’s age of regulation
Safety legislation and data sharing in Asia is making progress but highlights a global challenge